imatinib mesylate has been researched along with Corneal Neovascularization in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avsar, T; Ceylan, D; Kilic, T; Oksal, MD; Tatarli, N | 1 |
1 other study(ies) available for imatinib mesylate and Corneal Neovascularization
| Article | Year |
|---|---|
Antiangiogenic Molecules Suppressed Meningioma-Induced Neovascularization: A Corneal Angiogenesis Study.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Corneal Neovascularization; Imatinib Mesylate; Meningeal Neoplasms; Meningioma; Neovascularization, Pathologic; Rats; Receptor, Platelet-Derived Growth Factor beta; RNA | 2022 |